Package 42385-921-48

{"route": ["ORAL"], "spl_id": "0e18774c-a32c-4961-9684-f5c6ffce64a1", "openfda": {"upc": ["0342385922301"], "unii": ["4MT4VIE29P"], "rxcui": ["402246", "402247", "664741"], "spl_set_id": ["c98e40ec-8a2c-4f19-b1c3-c82f708c2490"], "manufacturer_name": ["Laurus Labs Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BLISTER PACK in 1 CARTON (42385-921-48)  / 6 CAPSULE in 1 BLISTER PACK (42385-921-06)", "package_ndc": "42385-921-48", "marketing_start_date": "20210430"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (42385-921-60)", "package_ndc": "42385-921-60", "marketing_start_date": "20210430"}], "brand_name": "Atazanavir", "product_id": "42385-921_0e18774c-a32c-4961-9684-f5c6ffce64a1", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "Protease Inhibitor [EPC]", "UDP Glucuronosyltransferases Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]"], "product_ndc": "42385-921", "generic_name": "Atazanavir", "labeler_name": "Laurus Labs Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atazanavir", "active_ingredients": [{"name": "ATAZANAVIR SULFATE", "strength": "200 mg/1"}], "application_number": "ANDA212579", "marketing_category": "ANDA", "marketing_start_date": "20210430", "listing_expiration_date": "20261231"}